West Pharmaceutical Services Inc. (WST) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    West Pharmaceutical Servi...

    NYSE: WST · Real-Time Price · USD
    261.69
    7.21 (2.83%)
    At close: Sep 26, 2025, 1:11 PM

    West Pharmaceutical Services Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.89B 2.95B 2.89B 2.83B
    Cost of Revenue
    		 1.89B 1.82B 1.75B 1.66B
    Gross Profit
    		 1B 1.13B 1.14B 1.17B
    Operating Income
    		 594.6M 710.9M 763.5M 758.7M
    Interest Income
    		 19.6M 28M 5.1M 1M
    Pretax Income
    		 600.2M 715.7M 700.6M 769M
    Net Income
    		 492.7M 593.4M 585.9M 661.8M
    Selling & General & Admin
    		 338.5M 353.4M 316.9M 361.9M
    Research & Development
    		 69.1M 68.4M 58.5M 52.8M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 407.6M 421.8M 375.4M 414.7M
    Interest Expense
    		 2.9M 8.8M 7.6M 8.5M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 2.3B 2.24B 2.12B 2.07B
    Income Tax Expense
    		 107.5M 122.3M 114.7M 107.2M
    Shares Outstanding (Basic)
    		 73M 74.3M 74.4M 74.4M
    Shares Outstanding (Diluted)
    		 73.7M 75.3M 75.8M 76.3M
    EPS (Basic)
    		 6.75 7.99 7.88 8.90
    EPS (Diluted)
    		 6.69 7.88 7.73 8.67
    EBITDA
    		 743.8M 844.1M 808.1M 879.7M
    EBIT
    		 588.4M 706.8M 687.5M 757.4M
    Depreciation & Amortization
    		 155.4M 137.3M 120.6M 122.3M

    Add to Watchlist